NOVEL BINDING PROTEINS COMPRISING A UBIQUITIN MUTEIN AND ANTIBODIES OR ANTIBODY FRAGMENTS

The present invention relates novel binding molecules comprising a ubiquitin mutein (Affilin®) and a monoclonal antibody or antibody fragment. The invention refers to bispecific and/or bivalent binding proteins or to a therapeutically or diagnostically active component. The invention further relates...

Full description

Saved in:
Bibliographic Details
Main Authors Hennicke Julia, Fiedler Erik, Liebscher Markus, Bosse-Doenecke Eva, Kahl Mathias, Knick Paul, Settele Florian
Format Patent
LanguageEnglish
Published 01.02.2018
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates novel binding molecules comprising a ubiquitin mutein (Affilin®) and a monoclonal antibody or antibody fragment. The invention refers to bispecific and/or bivalent binding proteins or to a therapeutically or diagnostically active component. The invention further relates to the use of these binding proteins' medicine, preferably for use in the treatment of cancer or autoimmune disorders.
Bibliography:Application Number: US201615549022